Long‐term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low‐dose IMRT salvage
Pediatric Blood & Cancer2012Vol. 60(4), pp. 688–693
Citations Over TimeTop 10% of 2012 papers
Jesse L. Berry, Rima Jubran, Jonathan W. Kim, Kenneth Wong, Simon R. Bababeygy, Hashem Almarzouki, Thomas C. M. Lee, A. Linn Murphree
Abstract
Kaplan-Meier estimates of eye survival of Group D eyes in bilateral patients at 12 months is 82% (95% confidence interval [CI] 70.1-89.7%); at 60 months eye survival is estimated to be 68% (95% confidence interval [CI] 55.4-82.8%). Systemic treatment for retinoblastoma demonstrated a high rate of globe preservation with acceptable complications and many eyes retaining functional vision.
Related Papers
- → Enucleated Weight/Enucleation Time, Is It Appropriate for Estimating Enucleation Skills for Holmium Laser Enucleation of the Prostate? A Consideration of Energy Consumption(2017)25 cited
- → Retinoblastoma: The Accuracy of Clinical Diagnosis in Children Treated by Enucleation(1983)24 cited
- → COBALT PLAQUES IN ADVANCED RETINOBLASTOMA(1983)10 cited
- Comparison of micromanipulation mechanical enucleation methods of bovine oocytes(2009)
- Analysis of related factors of 305 cases with eyeball enucleation(2014)